clock.health

clock.health is a biotechnology company developing therapies to reverse cellular ageing and extend healthspan by decoding the biological programmes that govern cell rejuvenation.

Using a proprietary model in which human induced pluripotent stem cells are artificially aged then permitted to self-rejuvenate, the company conducts genome-wide CRISPR screens to identify the genes and pathways responsible.

Validated targets are progressed towards therapeutic interventions, with initial human studies focusing on topical and nutraceutical applications ahead of systemic therapies.